Stockscreener 앱 받기
0.4951
10.47%
-0.0579
시간 외 거래:
.52
0.0249
+5.03%
전일 마감가:
$0.553
열려 있는:
$0.4775
하루 거래량:
365.15K
Relative Volume:
1.74
시가총액:
$43.79M
수익:
$8.90M
순이익/손실:
$-4.57M
주가수익비율:
-8.9047
EPS:
-0.0556
순현금흐름:
$-1.84M
1주 성능:
+2.91%
1개월 성능:
+22.82%
6개월 성능:
+87.54%
1년 성능:
-14.52%
1일 변동 폭
$0.4501
$0.5182
1주일 범위
$0.4401
$0.5796
52주 변동 폭
$0.2181
$0.675
Milestone Scientific Inc. Stock (MLSS) Company Profile
명칭
Milestone Scientific Inc.
전화
973-535-2717
주소
220 South Orange Avenue, Livingston, NJ
Compare MLSS vs ISRG, BDX, ALC, RMD, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MLSS
Milestone Scientific Inc.
|
0.4951 | 46.81M | 8.90M | -4.57M | -1.84M | -0.0556 |
ISRG
Intuitive Surgical Inc
|
394.51 | 141.76B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.40 | 50.00B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
74.25 | 35.57B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
224.46 | 32.78B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.74 | 31.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
Milestone Scientific Inc. Stock (MLSS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-09-16 | 개시 | Northland Capital | Market Perform |
| 2018-11-16 | 재확인 | Maxim Group | Buy |
| 2016-12-23 | 재확인 | Maxim Group | Buy |
| 2015-12-11 | 개시 | Maxim Group | Buy |
Milestone Scientific Inc. 주식(MLSS)의 최신 뉴스
Transcript: Milestone Scientific Q2 2026 Earnings Conference Call - Sahm
Milestone Scientific’s Global Exposure: Geopolitical and China Risks Threaten Supply Chain and Revenue - TipRanks
Milestone Scientific Inc (MLSS) (Q2 2026) Earnings Call Highligh - GuruFocus
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Milestone Scientific Releases Q2 2026 Financial Results - AlphaStreet
Milestone Scientific Q3 Sales Guidance Misses $2.510M Estimate - scanx.trade
Earnings call transcript: Milestone Scientific posts Q2 2026 revenue growth By Investing.com - Investing.com India
MLSS: Q2 revenue up 22% year-over-year, medical segment surges, 2026 guidance reaffirmed - TradingView
Earnings call transcript: Milestone Scientific posts Q2 2026 revenue growth - Investing.com
Milestone Scientific Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
Milestone Scientific Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Milestone Scientific Reports 231% Growth in Medical Revenue, Announces VA and DoD Distribution Agreement and Reaffirms 2026 Outlook - Quiver Quantitative
Milestone Scientific Reports Financial Results for Second Quarter 2026 - marketscreener.com
Milestone Scientific Inc (MLSS) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% on ... By GuruFocus - Investing.com Canada
Milestone Scientific Q2 Results: Sales up 22% YoY to $2.841M - scanx.trade
Milestone Scientific (NYSE: MLSS) grows revenue 22% but flags going concern risk - Stock Titan
Milestone Scientific Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Earnings To Watch: Milestone Scientific Inc (MLSS) Q2 2026 -- GF Value Sees 13% Upside - Yahoo Finance
Milestone Scientific to host Q2 earnings conference call - Bitget
Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call - The Manila Times
Computerized drug-delivery developer sets Aug. 14 results call - Stock Titan
Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System - The Manila Times
Epidural Device to Be Marketed Across VA and Military Systems - Stock Titan
Milestone Scientific signs federal distribution deal with Red One - scanx.trade
Milestone Scientific Inc. (NYSE: MLSS) investors back higher share and equity plan limits - Stock Titan
Milestone Scientific Shareholders Approve Governance and Equity Changes - TipRanks
Milestone Scientific, Inc. Revenue Breakdown – AMEX:MLSS - TradingView
Milestone Scientific Directors Elect Conversion of Bridge Notes - TipRanks
Milestone Scientific (NYSE: MLSS) directors plan bridge note conversions - Stock Titan
Milestone Scientific Inc. (MLSS) Gains 3.13% as Stock Tests Key Resistance at $0.42Volume Breadth - dars.gov.et
Milestone Scientific Inc (MLSS) Cash Flow - TradingKey
Milestone Scientific Inc (MLSS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TradingKey - TradingKey
Milestone Scientific Inc (MLSS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Milestone Scientific Inc (MLSS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Milestone Scientific Inc (MLSS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MLSS|Milestone Scientific Inc|Price:0.390|Chg%:-0.008 - TradingKey
MLSS|Milestone Scientific Inc|Price:0.414|Chg%:+0.024 - TradingKey
Milestone Scientific expects Q2 revenue of $2.8M - MSN
MLSS Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SentimentPeak Earnings Alert - dars.gov.et
Top Five Milestones in Space Exploration History - Encyclopedia Britannica
Milestone Scientific Launches First Phase of AI Strategy With Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026 - 富途牛牛
Milestone's Milo AI Pilot Will Answer Questions at ASPN 2026 - Stock Titan
Milestone Scientific (MLSS) Gains 3.38% as Stock Tests Key Resistance LevelDip Buy Trade - dars.gov.et
China’s Long March 10B rocket successfully launches—and lands—in a global spaceflight milestone - Scientific American
NewcelX Appoints Diabetes Research Leader Camillo Ricordi to Scientific Advisory Board Following FDA Pre-IND Milestone - Quiver Quantitative
Milestone Scientific Inc. Q1 2026 Earnings: Narrower Than Expected Loss, Stock SlipsOperating Income Trends - dars.gov.et
Price to sales forward of Milestone Scientific, Inc. – AMEX:MLSS - TradingView
MLSSMilestone Scientific Inc Dividends - Finviz
Milestone Scientific Inc. (MLSS) Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Cost Discipline - dars.gov.et
Milestone Scientific (MLSS) Slides 2.34% as Stock Tests Key Support LevelsVolume Weighted Price - dars.gov.et
Milestone Scientific Inc. (MLSS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.90%
1.18%
자본화:
|
볼륨(24시간):